Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
| Image |  |
|---|---|
| Description | scientific article published on 23 February 2018 |
| Author/s |
author: Kyriaki A Boki Prodromos Sidiropoulos Petros P Sfikakis Maria G Tektonidou Abdülsamet Erden Stylianos Panopoulos Dimitrios Vassilopoulos Christina Adamichou Dimitrios T Boumpas |
| Publication date | February 23, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |